Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
10.84
-0.04 (-0.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
Third Harmonic Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Third Harmonic Bio stock have an average target of 20.33, with a low estimate of 18 and a high estimate of 23. The average target predicts an increase of 87.55% from the current stock price of 10.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 9, 2024.
Analyst Ratings
The average analyst rating for THRD stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $12 → $20 | Hold → Buy | Upgrades | $12 → $20 | +84.50% | Aug 9, 2024 |
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +112.18% | Jun 18, 2024 |
| Raymond James | Raymond James | Buy Initiates $18 | Buy | Initiates | $18 | +66.05% | Jun 7, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $5 → $7 | Hold | Maintains | $5 → $7 | -35.42% | Aug 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $34 → $5 | Buy → Hold | Downgrades | $34 → $5 | -53.87% | Dec 16, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.12
from -0.78
EPS Next Year
-1.52
from -1.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.01 | -1.47 | -1.84 | |||
| Avg | -1.12 | -1.52 | -2.09 | |||
| Low | -1.21 | -1.59 | -2.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.